This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medicalscience advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements.
Are you ready to explore the fascinating world of MedicalScience Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals.
That statement, coined by one of my colleagues at Healthware MedComms , summarises the changing state of communications between pharmaceutical organisations and their healthcareprovider (HCP) stakeholders.
Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact.
The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.
A Clinical sales specialist in medical sales is a professional in the healthcare industry who plays a crucial role in promoting and selling medical and healthcare products or services to healthcareproviders, such as hospitals, clinics, and private practices. The magnitude of the rewards far outweighs them.
It also highlighted that digital provides new ways for MA members to connect and engage with stakeholders. Healthcareproviders (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past.
Healthcare organizations can leverage schema markup to highlight things users often search for (e.g., contact information, medical specialties, accepted insurances, business hours, location, patient testimonials, and more) directly on the SERP. This markup is often enumerated with specific specialties (e.g.,
Did you know that a well-trained pharmaceutical sales rep can be the driving force behind a healthcareprovider's decision-making process? Training focused heavily on face-to-face interactions, with an emphasis on building relationships with healthcareproviders. That’s right. But it wasn't just about being personable.
Kaitlin Anstett , Senior Medical Advisor at Theratechnologies , will sit down with Natalie Yeadon , Co-founder & CEO of Impetus Digital , to share her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important stakeholders in the “new normal.” Sign up now!
These] are life-saving medications. And patients can die when we do not have these readily available,” he says. As a result, healthcareproviders need to rely on generic manufacturers, but there are only a few who make them, he explains. Here, the long-term shortages can be attributed to two factors, says Page.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content